SCHEMBL25663172

SCHEMBL25663172

CNc1cc2c(Nc3cccc(-c4c(F)cc(F)cc4F)c3)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 4/20 0.60
▸ KDR P35968 3/20 0.60
▸ EGFR P00533 18/20 0.58
▸ ERBB2 P04626 6/20 0.58
▸ KIT P10721 3/20 0.57
▸ ERBB3 P21860 3/20 0.57
▸ ERBB4 Q15303 3/20 0.57
▸ CIT O14578 2/20 0.57
▸ GAK O14976 2/20 0.57
▸ EPHB6 O15197 2/20 0.57
▸ RIPK2 O43353 2/20 0.57
▸ STK17B O94768 2/20 0.57
▸ STK10 O94804 2/20 0.57
▸ ABL1 P00519 2/20 0.57
▸ LCK P06239 2/20 0.57
▸ LYN P07948 2/20 0.57
▸ RET P07949 2/20 0.57
▸ MET P08581 2/20 0.57
▸ HCK P08631 2/20 0.57
▸ FGR P09769 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25662767 0.92 SRC (0.61) SRCKDREGFRERBB2KIT
SCHEMBL26056082 0.91 EGFR (0.64) SRCKDREGFRERBB2KIT
SCHEMBL25663079 0.90 EGFR (0.58) SRCKDREGFRERBB2KIT
SCHEMBL25662957 0.88 EGFR (0.59) SRCKDREGFRERBB2RET
SCHEMBL25258136 0.87 EGFR (0.76) SRCKDREGFRERBB2KIT
SCHEMBL30429793 0.87 EGFR (0.76) SRCKDREGFRERBB2KIT
SCHEMBL25663071 0.87 EGFR (0.55) SRCKDREGFRERBB2KIT
SCHEMBL25662550 0.84 EGFR (0.57) SRCKDREGFRERBB2FLT4
SCHEMBL30429394 0.84 EGFR (0.71) SRCKDREGFRERBB2KIT
SCHEMBL25260227 0.84 EGFR (0.71) SRCKDREGFRERBB2KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4194443-A1 EFGR INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2023-06-14 — — EP disclosed
Send feedback